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The effect of body mass index and fasting glucose
on the relationship between blood pressure and
incident diabetes mellitus: a 5-year follow-up study
Won Young Lee1,6, Chang Hee Kwon2,6, Eun Jung Rhee1, Jeong Bae Park3, Young Kwon Kim4,
Sook Young Woo5, Seonwoo Kim5 and Ki Chul Sung2
There is no consensus on the relationship between high blood pressure (BP) and incident diabetes mellitus (DM). Therefore,
the aim of the current study was to investigate the independent association between BP and incident DM and identify the
metabolic components that inﬂuence incident DM in Korean subjects. The current study included 14054 non-diabetic subjects
(mean age of 41 years) at the start of the study who were followed for an average of 5 years. We measured the risk for incident
DM according to the subjects’ baseline BP. Subjects were separated into three groups as follows: normotensive (o120/
80mmHg), pre-hypertensive (120/80mmHg pBP o140/90mmHg) and hypertensive (X140/90mmHg). The overall
incidence of DM was 1.8% (246 subjects), comprising 0.9% of the normotensive group, 1.9% of the pre-hypertensive group
and 4.0% of the hypertensive group (Po0.01). Within the hypertensive group, subjects with high body mass index (BMI) and
high fasting-glucose levels were 40 times more likely to develop DM compared with those with low BMI and low glucose levels
(0.3 vs. 13.2%, P¼0.001). The risk for incident DM was signiﬁcantly higher in the hypertensive group compared with that in
the normotensive group (OR 3.41 vs. 1.00, Po0.0001). However, the signiﬁcance disappeared after making adjustments for
the baseline BMI and fasting glucose levels (OR 1.18 vs. 1.00, P¼0.83). We found that the signiﬁcance of high BP in
predicting incident DM was inﬂuenced by the baseline BMI and fasting glucose levels of the subjects.
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INTRODUCTION
Hypertension often co-exists with type 2 diabetes mellitus (DM). 1–4 It
is estimated that 40–80% of diabetic patients have a twofold increased
risk of hypertension compared with that of normoglycemic indivi-
duals.1,3 Furthermore, the co-existence of hypertension and DM, such
as in patients with metabolic syndrome, increases the risk of cardio-
vascular disease by approximately twofold over 5–10 years compared
with subjects without metabolic syndrome.5 A multifactorial treat-
ment approach is essential for the prevention of cardiovascular disease
for patients with DM as observed in recent intervention trials.6
A few studies have suggested that high blood pressure (BP) is a risk
factor for the later development of type 2 DM.7,8 In the Women’s Health
Study, baseline BP is an independent predictor for the new-onset of
type 2 DM among women that had been healthy at baseline after
adjusting for multiple confounding factors such as body mass index
(BMI) but they did not include baseline glucose level as a confounder.7
The Framingham Offspring Study has reported that a family history of
diabetes, obesity, and metabolic syndrome also predicts the develop-
ment of type 2 DM; however, hypertension only had a marginal impact
on the development of diabetes after adjusting for glucose and BMI.8
Despite the numerous studies that have attempted to clarify the
relationship between high BP and the development of DM, no
consensus has been reached concerning whether high BP itself or
other metabolic components that affect hypertension and diabetes
concurrently inﬂuence the development of type 2 DM in Asian
subjects with high baseline BP. Furthermore, little is known about
the relationship between the relative degree of hypertension and the
later development of DM. Therefore, we hypothesized that the risk for
the development of type 2 DM was higher in subjects with elevated
baseline BP. We investigated the relationship between BP and incident
DM and identiﬁed metabolic components that inﬂuenced the risk of
incident DM in an initial large cohort of healthy Korean subjects.
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Subjects
We retrospectively reviewed the electronic medical records of subjects
(mean age of 41.2±6.1 years, males were 41.6±5.9-years old, females were
40.2±6.5-years old) who had participated regularly in a general health check-
up program that was run through a health promotion center at the Kangbuk
Samsung Hospital in Seoul, Korea, between 2003 and 2008. The purposes of
the medical health checkup program were to promote the health of employees
through regular health checkups and to detect diseases at an early stage. Most
of the examinees were employees and their families from various industrial
companies across the country. The cost of these medical examinations was
largely paid by the employers, and a considerable proportion of the examinees
were seen annually or biannually. Therefore, we were able to follow-up with
these subjects for 5 years.
Study design
A total of 15638 subjects were included. Among them, subjects with a known
history of diabetes (N¼179), a fasting plasma glucose level X6.99mmoll 1
(126mgdl 1) that was detected during the initial evaluation in 2003 (N¼382),
or those with missing medical information (N¼241 lacked alcohol use history,
361 lacked a smoking record, 309 lacked exercise data and 581 lacked other
necessary data) were excluded from the study. Finally, 14054 individuals were
selected for the analyses. This study was approved by the Institutional Review
Board of the Kangbuk Samsung Hospital.
The health status evaluation consisted of a full medical history, physical
examination and a comprehensive blood test. From the available data, we
extracted the following information: demographics (age and gender), anthro-
pometric measurements (height and weight), BP (systolic and diastolic) and
pulse rate. The heights and weights of the subjects were measured when the
subjects were dressed in examination gowns without shoes. The BMI was
calculated as the weight in kilograms divided by the squared value of the height
in meters (kgm 2). The social history was obtained using a self-questionnaire.
Smoking history was categorizedintonever smoked, currently smoke or smoked
in the past. Exercise status was categorized by some exercise (subjects who
performed any type of regular exercise at least once a week) and no exercise.
Measurement of laboratory data
BP was measured using a standardized sphygmomanometer after at least 5min
of rest according to the Hypertension Detection and Follow-up Program
protocol.9 Participants were divided into three groups based on their baseline
BP status according to the seventh report of the Joint National Committee on
prevention, detection, evaluation and treatment of high BP (JNC 7). These
categories included normotensive (systolic BPo120mmHg and diastolic BP
o80mmHg), pre-hypertensive (120/80mmHgpBPo140/90mmHg) and
hypertensive (X140/90mmHg or presently taking anti-hypertensive medica-
tion) groups. Newly developed DM was deﬁned as a fasting glucose
X126mgdl 1 based on a laboratory examination in 2008 or the self-reported
use of anti-diabetic drugs.
Laboratory examinations were performed after at least 12h of fasting.
Glucose was measured using the hexokinase method (Advia 1800 Autoanalyzer;
Bayer Diagnostics, Leverkusen, Germany) with an intra-measurement coefﬁ-
cient of variance of 0.98–1.34%. An enzymatic calorimetric test (Advia 1800,
Autoanalyzer; Bayer Diagnostics) was used to measure the total cholesterol and
triglyceride concentrations using a coefﬁcient of variance of 1.32–1.55% for
total cholesterol and 0.89–1.38% for triglycerides. The selective inhibition
method was used to measure high-density lipoprotein cholesterol concentra-
tion (Advia 1800 Auto-analyzer; Bayer Diagnostics) using a coefﬁcient of
variance of 2.64–3.03%.
Statistical analysis
Descriptive data are presented as the means±standard deviation, the median
with interquartile range if the parameters were non-parametrically distributed,
or the numbers of subjects with percentages within parentheses. The w2-test was
used to compare the proportion of the subjects between different groups
divided by the dichotomized groups of metabolic parameters and BP status.
One-way analysis of variance and Kruskal–Wallis tests were used to analyze the
statistical differences of the mean and median values of various parameters
among different groups divided by the BP status.
We used logistic regression to calculate the odds ratios for the development
of diabetes after adjusting for confounders. In the multivariate models, we
included variables such as baseline age, BMI, plasma glucose level, smoking,
alcohol consumption and regular exercise. Interaction of the BP status with
baseline BMI and glucose status in the development of diabetes was analyzed
using logistic regression analyses with Bonferroni’s correction. Receiver-oper-
ating characteristics curve analyses were performed to identify the predictors
for diabetes. Statistical data analyses were performed using SPSS version 12.0
software (SPSS, Chicago, IL, USA). All of the reported P-values were two-tailed,
and those less than 0.05 were considered statistically signiﬁcant.
RESULTS
At the start of the current study in 2003, 14.9% of all subjects
had hypertension, 39.1% had prehypertension and 45.9% had normal
BP. Individuals with higher BP tended to be older and had higher
BMI, fasting glucose and triglyceride levels and lower high-density
lipoprotein cholesterol levels compared with those of subjects with
normal BP. A higher percentage of subjects who were male and had
an increased alcohol intake and a history of smoking (past or current)
were found in the pre-hypertensive and hypertensive groups (Table 1).
During the 5-year follow-up period, 246 (1.8%) subjects developed
DM. The incidences of these new diagnoses occurred at the rates of
4.0% in the hypertensive group, 1.9% in the pre-hypertensive group
and 0.9% in the normotensive group (Table 2). The analyses that were
performed in the two groups considered baseline BMI and revealed
that more subjects in the obese group (BMI X25kgm 2) developed
diabetes compared with those in the non-obese group (BMI
o25kgm 2), which was independent of BP grouping (P¼0.001)
(Table 2). Furthermore, new diagnoses of DM frequently occurred
within the pre-hypertensive and hypertensive groups compared with
those within the normotensive group independent of BMI. There were
no interactions between the baseline BMI status and the BP status in
the development of DM. In addition, subjects with higher baseline
glucose levels were more likely to develop DM independent of BP
grouping. Conversely, patients in the hypertensive group developed
more diabetes independent of their baseline glucose levels (Table 2).
There was a signiﬁcant interaction between the baseline fasting glucose
status and BP status in the development of DM (P¼0.03).
BMI and baseline fasting glucose levels were analyzed together in
subjects with high baseline BMI and high baseline glucose levels.
The results indicate that more subjects in the hypertensive group
developed incident DM compared with subjects in the normotensive
group (13.2 vs.8 . 0 % ,P¼0.044). When the analyses were conducted
only in hypertensive subjects, the subjects with high BMI and high
glucose levels were at least 40 times more likely to develop diabetes
compared with those with low baseline BMI and low glucose levels
(0.3 vs.1 3 . 2 % ,P¼0.001) (Table 2).
When the risk for the development of DM was analyzed according
to the baseline BP status, the hypertensive group had a signiﬁcantly
higher risk of developing diabetes compared with the normotensive
group (reference group) with an odds ratio of 3.41 after adjusting for
age, sex, alcohol use, smoking status and exercise level (Table 3).
However, this signiﬁcance disappeared when BMI and baseline fasting
glucose levels were included as confounders (Table 3). This result is
consistent in the analyses of men and women (data not shown).
Receiver-operating characteristics curve analyses were performed
using the confounders as predictors for the development of diabetes.
The baseline glucose level had the highest area under the receiver-
operating characteristics curve value, and BMI had the second highest
value (Table 4).
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In the current study, we found that high baseline BP (pre-hyperten-
sion and hypertension) was associated with an increased risk of
developing DM over a 5-year follow-up period. However, after
adjusting for baseline BMI and fasting glucose levels, this signiﬁcance
disappeared. Therefore, these results suggest that BMI and fasting
glucose levels are important factors leading to the development of
DM in subjects with hypertension.
Patients with essential hypertension often have impaired glucose
tolerance, which is evident in pre-hypertensive subjects.10,11 The risk
for the development of DM in different groups that were categorized
based on baseline BP in the current study was similar to that reported
in previous studies.1,7 Another recent study that was performed in
Turkish subjects has reported the predictability of pre-hypertension
for metabolic syndrome, diabetes and coronary artery disease as well
as the cardiometabolic risk inwomen, which is independent of obesity.
These ﬁndings do not agree with the results of our study.12 The main
reason for the discrepancy between the previous studies and the
present study may be that the previous studies did not adjust for
the baseline fasting glucose level, which is one of the most important
factors for future incident DM.
The cause for the coincidental occurrence of diabetes and hyperten-
sion may be partly explained by the common features of obesity,
insulin resistance, increased sympathetic activity and an activated
Table 2 The incidence of newly developed diabetes mellitus according to baseline blood pressure status, body mass index and fasting glucose
levels
Normotensive group (%) Pre-hypertensive group (%) Hypertensive group (%) Total P-value
All subjects 59/6457 (0.9) 104/5498 (1.9) 83/2099 (4.0) 246/14054 (1.8) o0.01
Body mass indexa
o25kgm 2 28/4982 (0.56) 33/3424 (0.96) 14/945 (1.48) 75/9351 (0.8)* 0.006
X25kgm 2 31/1475 (2.1) 71/2074 (3.42) 69/1154 (5.98) 171/4703 (3.63)* o0.01
Fasting blood glucoseb
o5.55mmoll 1 6/5533 (0.11) 13/4176 (0.311) 10/1361 (0.731) 29/11070 (0.261)* o0.01
X5.55mmoll 1 53/924 (5.7) 91/1322 (6.9) 73/738 (9.9) 217/2984 (7.3)* 0.004
BMI and FBS combined
o25kgm 2 and o5.55mmoll 1 2/4394 (0.05) 3/736 (0.11) 2/670 (0.3)c 7/7800 (0.09) 0.114
X 25kgm 2 and X5.55mmoll 1 27/336 (8.0) 61/634 (9.6) 61/463 (13.2)c 49/1433 (10.4) 0.044
Abbreviations: BMI, body mass index; FBS, fasting blood sugar.
*P¼0.001 in differences in the proportions between the groups analyzed by w2-test.
aIn interaction analyses, there was no signiﬁcant interaction between baseline blood pressures status and baseline body mass index status in the development of diabetes.
bIn interaction analyses, there was a signiﬁcant interaction between baseline blood pressure status and baseline fasting glucose status in the development of diabetes. This signiﬁcant interaction
was signiﬁcant even after adjustment for confounding variables such as, age, sex, alcohol, smoking status and exercise status. A total of 5.55mmoll 1 is equal to 100mgdl 1.
cWhen w2-test was performed among the groups with BMI status and FBS status combined and BP status groups, there were signiﬁcant differences between the groups with P¼0.001.
Table 1 Baseline characteristics of the subjects divided by baseline blood pressure status
Normotensive group Pre-hypertensive group Hypertensive group Total P-valuea
Number of the participants
(%;95% CI)
6457 (45.94; 45.12–46.77) 5498 (39.1; 38.31–39.93) 2099 (14.94; 14.35–15.54) 14054 —
Age (years) 40.3±5.6 41.1±5.8 43.9±7.3 41.2±6.1 o0.01
Sex: male subjects (%) 3671 (56.9) 4452 (81.0) 1804 (85.9) 9927 (70.6) o0.01
Fasting blood glucose (mmoll 1)5 . 0 6 ±0.44 5.22±0.47 5.34±0.51 5.17±0.48 o0.01
Triglyceride (mmoll 1) 1.15 (0.82–1.66) 1.44 (1.02–2.03) 1.58 (1.15–2.25) 1.32 (0.93–1.90) o0.01
BMI (kgm 2)2 2 . 9 9 ±2.68 24.23±2.75 25.39±2.78 23.84±2.86 o0.01
HDL-C (mmoll 1)1 . 4 3 ±0.30 1.39±0.28 1.40±0.28 1.41±0.29 o0.01
SBP (mmHg) 104.4±7.3 119.0±6.6 134.4±13.3 114.6±13.5 o0.01
DBP (mmHg) 67±5.2 78±4.0 90±8.5 74±10.0 o0.01
Regular exercise (yes or no) 2134 (33.0) 1979 (36.0) 871 (41.5) 4984 (35.5) o0.01
Alcohol (g per day) 8.2±12.8 12.1±15.9 15.5±18.6 10.8±15.2 o0.01
Smoking history
Never 3783 (58.60) 2454 (44.60) 897 (42.70) 7134 (50.80) o0.01
Ex 919 (14.20) 1244 (22.60) 565 (26.90) 2728 (19.40)
Current 1755 (27.20) 1801 (32.80) 637 (30.30) 4193 (29.80)
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure.
Data are mean±SD, median (interquartile range) or counts (percentages).
aParameters with parametric distribution are analyzed by one-way ANOVA test, and non-parametrically distributed parameter such as triglyceride level is analyzed by Kruskal-Wallis test. Differences
in proportions of the subjects between the groups are compared with w2-test.
High blood pressure and incident diabetes mellitus
WY Lee et al
1095
Hypertension Researchrenin-angiotensin-aldosterone system.13,14 The causative role of
increased sympathetic activity on the development of DM may be
supported by a recent study reporting the linear relationship between
increased baseline heart rates with the future development of obesity
and diabetes in a 20-year prospective study.15 However, this mechan-
ism is challenged by the increased risk for new-onset diabetes in
clinical trials using beta-blockers compared with that in clinical trials
with other anti-hypertensives.16 In contrast, the reduced incidence of
new-onset diabetes in trials using angiotensin-converting enzyme
inhibitors or angiotensin receptor blockers suggests the deleterious
effects of an activated renin-angiotensin system on the development of
diabetes.16
Racial differences in the characteristics of type 2 DM have been
reported. Caucasians had the highest BMI and fat percentage of the
four ethnic groups (blacks, whites, Asians and Puerto Ricans).
African–Americans had a lower body fat percentage compared with
Caucasians. In addition, Asians had lower values compared with
Caucasians at a similar age, sex and BMI.17,18 Asian people have a
tendency to develop DM with a lesser degree of obesity at a younger
age and display a ‘metabolically obese’ phenotype (that is normal body
weight with increased abdominal adiposity).19 A defect in the insulin
secretory capacity has been reported more frequently in Asians
compared with people of other ethnicities despite similarities in
BMI.17,20 Among Asians with genetically determined lower levels of
insulin secretion, a small increase in weight may accelerate the
development of diabetes. In the current study, the increased risk for
the development of DM among hypertensive subjects may be attrib-
uted to elevated BMI and baseline hyperglycemia. We conﬁrmed that
BMI is an important factor to predict the development of type 2 DM
in Korean subjects.
The current study had several limitations. First, new-onset DM was
deﬁned using the fasting glucose level or a self-reported medical
history of anti-diabetic drugs. However, no oral glucose tolerance
test was performed. The difference between the previous studies and
the present study may be explained by the fact that the present study
deﬁned new-onset DM based on fasting glucose levels alone but not
post-prandial glucose levels. Baseline hypertension may potentially be
used as an independent predictor for incident DM in Asians if new-
onset DM is deﬁned using fasting glucose and post-prandial glucose
levels. Second, although we obtained the medical history for the
presence of hypertension at the beginning of the study, we did not
determine which medications were being used to treat baseline
hypertension in the hypertensive group. Third, a family history of
diabetes was not included in the analyses. Fourth, our study cohort
was relatively homogenous and predominantly male, consisting of
industrial employees or their family members. Therefore, the external
validity of our results cannot be determined. In addition, we were
more easily able to follow-up with healthy subjects compared with
subjects with chronicor serious illnesses, which may have introduced a
selection bias into our analyses. Further studies are required to
measure the biochemical parameters such as the role of pro-inﬂam-
matory cytokines, endothelial function and indices of insulin function
in order to identify pathophysiological explanations for our ﬁndings.
Such studies may help to clarify the metabolic abnormalities that link
hypertension and the development of DM.
The current study has several strengths. Our sample size is very
large and secondary compared with the sample size used in the
Women’s Health Study to evaluate the relationship between baseline
BP and the development of DM.7 Our study is the largest study
performed with Asians, and we followed the subjects for a long period.
These strengths outweigh any possible biases of our study.
In conclusion, it is important to emphasize intensive lifestyle
modiﬁcations to prevent new-onset DM in hypertensive patients,
especially in patients with high BMI and high glucose levels. Among
patients with the same BP, the baseline BMI and glucose levels
signiﬁcantly inﬂuence the risk of incident DM. The correction of
metabolic components as a whole rather than focusing on BP control
alone is a better strategy to prevent the development of DM in
hypertensive subjects.
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